http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1711488-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2005-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055998c50f4a3b2f078ffc45b8917e63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d998a1d107c6bc6020346ea508e2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972355528b1f5002e1a3511836eda575 |
| publicationDate | 2006-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1711488-A1 |
| titleOfInvention | Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
| abstract | Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of Formula (I) or stereoisomers or prodrugs or solvates or pharmaceutically acceptable salts thereof, wherein A, B, J, K, Z, R, Ra, Rb, Rc, and Rd, are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds. |
| priorityDate | 2004-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1626.